19 research outputs found
p73: A Multifunctional Protein in Neurobiology
p73, a transcription factor of the p53 family, plays a key role in many biological processes including neuronal development. Indeed, mice deficient for both TAp73 and ΔNp73 isoforms display neuronal pathologies, including hydrocephalus and hippocampal dysgenesis, with defects in the CA1-CA3 pyramidal cell layers and the dentate gyrus. TAp73 expression increases in parallel with neuronal differentiation and its ectopic expression induces neurite outgrowth and expression of neuronal markers in neuroblastoma cell lines and neural stem cells, suggesting that it has a pro-differentiation role. In contrast, ΔNp73 shows a survival function in mature cortical neurons as selective ΔNp73 null mice have reduced cortical thickness. Recent evidence has also suggested that p73 isoforms are deregulated in neurodegenerative pathologies such as Alzheimer’s disease, with abnormal tau phosphorylation. Thus, in addition to its increasingly accepted contribution to tumorigenesis, the p73 subfamily also plays a role in neuronal development and neurodegeneration
p73 Regulates Primary Cortical Neuron Metabolism: a Global Metabolic Profile
The transcription factor p73 has been demonstrated to play a significant role in survival and differentiation of neuronal stem cells. In this report, by employing comprehensive metabolic profile and mitochondrial bioenergetics analysis, we have explored the metabolic alterations in cortical neurons isolated from p73 N-terminal isoform specific knockout animals. We found that loss of the TAp73 or ΔNp73 triggers selective biochemical changes. In particular, p73 isoforms regulate sphingolipid and phospholipid biochemical pathway signaling. Indeed, sphinganine and sphingosine levels were reduced in p73-depleted cortical neurons, and decreased levels of several membrane phospholipids were also observed. Moreover, in line with the complexity associated with p73 functions, loss of the TAp73 seems to increase glycolysis, whereas on the contrary, loss of ΔNp73 isoform reduces glucose metabolism, indicating an isoform-specific differential effect on glycolysis. These changes in glycolytic flux were not reflected by parallel alterations of mitochondrial respiration, as only a slight increase of mitochondrial maximal respiration was observed in p73-depleted cortical neurons. Overall, our findings reinforce the key role of p73 in regulating cellular metabolism and point out that p73 exerts its functions in neuronal biology at least partially through the regulation of metabolic pathways
TAp73 knockout mice show morphological and functional nervous system defects associated with loss of p75 neurotrophin receptor
This work has been supported by the Medical Research Council (Leicester, UK); grants from “Alleanza contro il Cancro” (ACC12-ACC6); Ministero Istruzione Università Ricerca/Progetti di Ricerca di Interesse Nazionale (RBIP06LCA9_0023); Associazione Italiana per la Ricerca sul Cancro (2008-2010_33-08); 5xmille (#9979); Telethon Grant GGPO9133; Ministero della Salute (Ricerca Oncologica 26/07); and IDI-IRCCS Grant RF06 (RF06 c.73, RF07 c.57, RF08 c.15, RF07 c.57) (to G.M.)
FASN activity is important for the initial stages of the induction of senescence
Senescent cells accumulate in several tissues during ageing and contribute to several pathological processes such as
ageing and cancer. Senescence induction is a complex process not well defined yet and is characterized by a series of
molecular changes acquired after an initial growth arrest. We found that fatty acid synthase (FASN) levels increase
during the induction of senescence in mouse hepatic stellate cells and human primary fibroblasts. Importantly, we also
observed a significant increase in FASN levels during ageing in mouse liver tissues. To probe the central role of FASN in
senescence induction, we used a small-molecule inhibitor of FASN activity, C75. We found that C75 treatment
prevented the induction of senescence in mouse and human senescent cells. Importantly, C75 also reduced the
expression of the signature SASP factors interleukin 1α (IL-1α), IL-1β and IL-6, and suppressed the secretion of small
extracellular vesicles. These findings were confirmed using a shRNA targeting FASN. In addition, we find that FASN
inhibition induces metabolic changes in senescent cells. Our work underscores the importance of C75 as a
pharmacological inhibitor for reducing the impact of senescent cell accumulationChildren with Cancer UK (Number: 14–178)BBSRC (BB/P000223/1)The Royal Society (RG170399)Nacional Health Institute Carlos IIIMiguel-Servet (CP13-00234)MINECO (SAF2016-78666 R
How Does p73 Cause Neuronal Defects?
The p53-family member, p73, plays a key role in the development of the central nervous system (CNS), in senescence, and in tumor formation. The role of p73 in neuronal differentiation is complex and involves several downstream pathways. Indeed, in the last few years, we have learnt that TAp73 directly or indirectly regulates several genes involved in neural biology. In particular, TAp73 is involved in the maintenance of neural stem/progenitor cell self-renewal and differentiation throughout the regulation of SOX-2, Hey-2, TRIM32 and Notch. In addition, TAp73 is also implicated in the regulation of the differentiation and function of postmitotic neurons by regulating the expression of p75NTR and GLS2 (glutamine metabolism). Further still, the regulation of miR-34a by TAp73 indicates that microRNAs can also participate in this multifunctional role of p73 in adult brain physiology. However, contradictory results still exist in the relationship between p73 and brain disorders, and this remains an important area for further investigation
Apoptotic cell death in disease-Current understanding of the NCCD 2023
Apoptosis is a form of regulated cell death (RCD) that involves proteases of the caspase family. Pharmacological and genetic strategies that experimentally inhibit or delay apoptosis in mammalian systems have elucidated the key contribution of this process not only to (post-)embryonic development and adult tissue homeostasis, but also to the etiology of multiple human disorders. Consistent with this notion, while defects in the molecular machinery for apoptotic cell death impair organismal development and promote oncogenesis, the unwarranted activation of apoptosis promotes cell loss and tissue damage in the context of various neurological, cardiovascular, renal, hepatic, infectious, neoplastic and inflammatory conditions. Here, the Nomenclature Committee on Cell Death (NCCD) gathered to critically summarize an abundant pre-clinical literature mechanistically linking the core apoptotic apparatus to organismal homeostasis in the context of disease
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Apoptosis is a form of regulated cell death (RCD) that involves proteases of the caspase family. Pharmacological and genetic strategies that experimentally inhibit or delay apoptosis in mammalian systems have elucidated the key contribution of this process not only to (post-)embryonic development and adult tissue homeostasis, but also to the etiology of multiple human disorders. Consistent with this notion, while defects in the molecular machinery for apoptotic cell death impair organismal development and promote oncogenesis, the unwarranted activation of apoptosis promotes cell loss and tissue damage in the context of various neurological, cardiovascular, renal, hepatic, infectious, neoplastic and inflammatory conditions. Here, the Nomenclature Committee on Cell Death (NCCD) gathered to critically summarize an abundant pre-clinical literature mechanistically linking the core apoptotic apparatus to organismal homeostasis in the context of disease